Literature DB >> 1493768

Comparison of enteral and intramuscular vitamin A supplementation in preterm infants.

J Landman1, A Sive, H D Heese, C Van der Elst, R Sacks.   

Abstract

Vitamin A deficiency associated with preterm delivery is not readily reversible using the recommended supplement of 1500 IU per day. It has been reported that 2000 IU of intramuscular vitamin A administered on alternate days for 28 days will correct the deficiency. The objective of this study was to compare this regime with the practice in our nursery of giving 5000 IU of vitamin A per day with the early introduction of feeds. The vitamin A status of ten preterm infants (mean gestation 30.5 weeks) who received intramuscular vitamin supplementation was compared with that of nine infants (mean gestation 30.7 weeks) given enteral vitamin A. Vitamin A status was evaluated on the 32nd day of life using plasma retinol and retinol-binding protein (RBP) concentrations and a modified relative dose response (RDR) test. Plasma retinol and RBP concentrations were similar in the two groups shortly after birth revealing vitamin A deficiency. By the 32nd day of life, plasma retinol and RBP concentrations had risen significantly in both groups and in 70% the modified RDR was normal. Differences between the groups were not observed irrespective of the method of vitamin A administration. None of the infants developed clinical or biochemical vitamin A toxicity. In most preterm infants who tolerate feeds, vitamin A deficiency can be corrected safely by supplementing the feeds with 5000 IU of vitamin A per day.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1493768     DOI: 10.1016/0378-3782(92)90143-5

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  9 in total

Review 1.  Vitamin A and preterm infants: what we know, what we don't know, and what we need to know.

Authors:  H Mactier; L T Weaver
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-03       Impact factor: 5.747

2.  Oral vitamin A supplementation in very low birth weight neonates: a randomized controlled trial.

Authors:  Sriparna Basu; Parul Khanna; Ragini Srivastava; Ashok Kumar
Journal:  Eur J Pediatr       Date:  2019-06-17       Impact factor: 3.183

Review 3.  Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birth weight infants.

Authors:  Brian A Darlow; P J Graham; Maria Ximena Rojas-Reyes
Journal:  Cochrane Database Syst Rev       Date:  2016-08-22

4.  Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease.

Authors:  S P Wardle; A Hughes; S Chen; N J Shaw
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-01       Impact factor: 5.747

5.  Characterization of the vitamin A transport in preterm infants after repeated high-dose vitamin A injections.

Authors:  A C Longardt; B Schmiedchen; J Raila; F J Schweigert; M Obladen; C Bührer; A Loui
Journal:  Eur J Clin Nutr       Date:  2014-10-15       Impact factor: 4.016

6.  Vitamin A to prevent bronchopulmonary dysplasia in extremely low birth weight infants: a systematic review and meta-analysis.

Authors:  Shunsuke Araki; Shin Kato; Fumihiko Namba; Erika Ota
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

7.  EARLY VITAMIN A SUPPLEMENTATION IMPROVES THE OUTCOME OF RETINOPATHY OF PREMATURITY IN EXTREMELY PRETERM INFANTS.

Authors:  Huiqing Sun; Rui Cheng; Zhansheng Wang
Journal:  Retina       Date:  2020-06       Impact factor: 3.975

8.  Early Vitamin A Supplementation for Prevention of Short-Term Morbidity and Mortality in Very-Low-Birth-Weight Infants: A Systematic Review and Meta-Analysis.

Authors:  Yanxiu Ye; Xiaoyan Yang; Jing Zhao; Jianghua He; Xiaoming Xu; Jiao Li; Jing Shi; Dezhi Mu
Journal:  Front Pediatr       Date:  2022-04-07       Impact factor: 3.569

9.  Enteral vitamin A for reducing severity of bronchopulmonary dysplasia in extremely preterm infants: a randomised controlled trial.

Authors:  Abhijeet Rakshasbhuvankar; Sanjay Patole; Karen Simmer; J Jane Pillow
Journal:  BMC Pediatr       Date:  2017-12-16       Impact factor: 2.125

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.